Obviousness

For a patent to be granted, an invention must be non-obvious. This means that the differences between the claimed invention and the prior art must be such that the claimed invention as a whole would not have been obvious to a person having ordinary skill in the art at the time the invention was made. The analysis of obviousness under 35 U.S.C. § 103 considers the scope and content of the prior art, the differences between the prior art and the claims at issue, the level of ordinary skill in the pertinent art, and secondary considerations of non-obviousness.

US Patent 12268475, titled "Wearable device for differential measurement on pulse rate and blood flow," describes a wearable device with a light source (comprising LEDs), one or more lenses, and a detection system. The device is configured to measure physiological parameters (pulse rate, blood flow) using differential measurements, and to increase the signal-to-noise ratio by increasing light intensity and/or comparing signals when the light source is on versus off. The patent also describes determining if the device is being worn by the user based on the output signal.

A Person of Ordinary Skill in the Art (POSITA) in this field would likely have a background in biomedical engineering, electrical engineering, or a related discipline, with experience in optical sensing, wearable devices, and signal processing for physiological measurements.

To assess the obviousness of US patent 12268475, we need to consider combinations of prior art that would lead a POSITA to the claimed invention with a reasonable expectation of success. Without specific prior art references explicitly detailing all the features of US12268475 in combination, it's challenging to provide definitive obviousness rejections. However, based on the definitions and context provided within US12268475, we can identify general areas of prior art that a POSITA would be familiar with and motivated to combine.

Potential Combinations of Prior Art for Obviousness:

Combination 1: Wearable Optical Sensors for Physiological Monitoring + Signal-to-Noise Ratio Improvement Techniques

• Prior Art Elements:

  • Wearable optical sensors for physiological monitoring: The patent itself defines an "apparatus adapted to be worn by a user" and "one or more biosensors adapted to be placed on the user, wherein one or more physiological parameters are measured." The patent mentions common applications like pulse rate monitoring and blood flow measurement. Prior art in wearable pulse oximeters, heart rate monitors, and other optical physiological sensors would be highly relevant. These devices commonly use light sources (e.g., LEDs) and detectors to measure blood flow and pulse rate through tissue (e.g., skin).
  • Techniques for improving signal-to-noise ratio (SNR) in optical measurements: The patent explicitly discusses increasing SNR by "increasing light intensity of at least one of the plurality of light emitting diodes from an initial light intensity" and by "comparing the first signal and the second signal" (light source off vs. on). These are well-known techniques in optical sensing to mitigate ambient light interference and improve measurement accuracy.
    • Light intensity adjustment: A POSITA would be aware that increasing light intensity generally leads to a stronger signal and thus a better SNR, especially in challenging measurement environments like biological tissue.
    • Differential measurement (light on/off): Subtracting a background measurement (light source off) from a measurement with the light source on is a standard practice to remove baseline noise and ambient light contributions in many optical sensing applications.

• Motivation for Combination: A POSITA developing a wearable device for physiological monitoring would be highly motivated to combine these elements to create a more robust and accurate device. The primary challenges in wearable optical sensing often revolve around motion artifacts and low signal-to-noise ratios due to skin absorption and ambient light. Therefore, the combination of a wearable optical sensor with known techniques to improve SNR (like intensity adjustment and light on/off differential measurements) would be an obvious design choice to enhance performance and reliability for accurate physiological parameter measurement.

Combination 2: Wearable Devices with Biosensors + User Detection Mechanisms

• Prior Art Elements:

  • Wearable devices with biosensors: As above, the concept of wearable devices incorporating biosensors to measure physiological parameters is well-established in the prior art, especially in fitness trackers and health monitors.
  • User detection mechanisms in wearable devices: The patent states the apparatus is "at least in part configured to determine, based at least in part on the output signal, that the apparatus is being worn by the user." Many existing wearable devices (e.g., smartwatches, fitness bands) include mechanisms to detect proper wearing or skin contact. This can be achieved through various means, including:
    • Capacitive sensors: Detecting skin contact.
    • Optical feedback: Analyzing the received optical signal; a lack of a plausible physiological signal (e.g., pulse) or an unusual signal pattern could indicate the device is not being worn correctly or at all.
    • Accelerometer data: Detecting movement consistent with being worn on a body part.

• Motivation for Combination: For wearable health devices, it is crucial to ensure that measurements are taken accurately when the device is properly positioned on the user. A POSITA would be motivated to integrate a user detection mechanism into a wearable biosensor to prevent erroneous readings, conserve battery life (by only operating the sensors when worn), and provide a better user experience. Using the existing output signal from the optical biosensor itself to infer whether the device is being worn (e.g., by checking for expected physiological signal characteristics) would be a logical and efficient integration of functionalities.

Combination 3: Optical Spectroscopy for Blood Constituent Measurement + Fiber Optics in Medical Devices + Signal Processing for Noise Reduction

• Prior Art Elements:

  • Optical spectroscopy for blood constituent measurement: The patent extensively discusses the use of near-infrared (NIR) and short-wave infrared (SWIR) spectroscopy for non-invasive monitoring of blood constituents like glucose, ketones, and HbA1c. This field of research is well-documented, with various techniques described (e.g., absorption spectroscopy, diffuse reflection spectroscopy).
  • Fiber optics in medical devices: The patent explicitly mentions that "Fiber optics may be conveniently used to guide the light to the patient as well as to transport the signal back to one or more detectors and receivers" in the context of caries detection apparatuses. The use of optical fibers for light delivery and collection in medical sensing applications is a known technique for flexibility, miniaturization, and remote sensing.
  • Signal processing for noise reduction in spectroscopic data: The patent refers to "Signal processing specially adapted for physiological signals or for diagnostic purposes for noise prevention, reduction or removal," and "Details of waveform analysis characterised by using transforms using Fourier transforms." These are standard signal processing techniques employed in spectroscopy to extract meaningful information from noisy signals.

• Motivation for Combination: When designing a device for non-invasive blood constituent measurement using spectroscopy, a POSITA would naturally consider fiber optics to deliver and collect light efficiently, especially for measurements at specific body sites or for miniaturized wearable designs. Given the inherent challenges of optical measurements in biological tissues (e.g., scattering, absorption by water and other compounds), employing advanced signal processing techniques, including noise reduction and Fourier transforms for spectral analysis, would be a necessary and obvious step to obtain accurate and reliable readings from the spectroscopic data.

General Motivation for Combining:

In all these scenarios, the motivation for a POSITA to combine these prior art elements would stem from the desire to create more effective, accurate, and user-friendly wearable medical devices. The problem-solution approach often drives obviousness: if known techniques exist to solve known problems (e.g., low SNR in optical sensing, need for user compliance detection), and those techniques are applicable to the field of wearable physiological monitoring, then combining them would be considered obvious. The rapidly advancing field of wearable health technology would further motivate a POSITA to integrate existing technologies to enhance device capabilities and address practical limitations.

It is important to note that a full obviousness rejection under 35 U.S.C. § 103 would require a detailed claim-by-claim analysis against specific prior art references, demonstrating how each limitation in the claims is present in, or rendered obvious by, the combination of those references. The above provides a conceptual framework based on the general technical disclosures within US12268475.